Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives

Abstract

Synergistic action of nanocarriers and CRISPR can be used for ablation of many genomic disorders. The enhanced delivery system is mediated by the endosomal escape mechanism. The synergistic strategizes is used for many neurodegenerative disorders as well as infection system.